Here’s a current, practical pneumonia treatment guide (IDSA/ATS-style 2019–2025 practice standards) with a correctional medicine overlay, since your setting changes the risk profile and operational decisions.
1. Pneumonia Types You Actually Use in Practice
In adults you mainly classify pneumonia as:
1) Community-Acquired Pneumonia (CAP)
- acquired outside hospital or within first 48 hours of admission
2) Hospital-Acquired Pneumonia (HAP)
- ≥48 hours after admission
3) Ventilator-associated pneumonia (VAP)
- intubated patients
4) Aspiration pneumonia
- risk from altered mental status, vomiting, intoxication
2. CAP (Community-Acquired Pneumonia): Core Guidelines
First step: decide outpatient vs inpatient
Outpatient if:
- stable vitals
- normal mental status
- can take oral meds
- no hypoxia
- low CURB-65 score
Inpatient if:
- hypoxia (SpO₂ <90–92%)
- RR ≥30
- hypotension
- confusion
- multilobar pneumonia
- significant comorbidities
3. Empiric Treatment of CAP (Outpatient)
Healthy adults (no comorbidities):
First-line:
- Amoxicillin OR
- Doxycycline
Macrolide only if local resistance is low (<25%):
- azithromycin
With comorbidities (DM, COPD, CKD, etc.):
Options:
- Amoxicillin-clavulanate + azithromycin (or doxycycline)
OR - respiratory fluoroquinolone:
- levofloxacin
- moxifloxacin
4. Inpatient CAP (non-ICU)
Standard regimen:
- Ceftriaxone + azithromycin
OR - respiratory fluoroquinolone alone
5. ICU CAP (severe)
Standard:
- beta-lactam (ceftriaxone, cefotaxime, or ampicillin-sulbactam)
PLUS - azithromycin OR respiratory fluoroquinolone
6. MRSA and Pseudomonas Coverage (critical decision point)
You DO NOT add this routinely.
You add coverage if risk factors exist.
MRSA risk factors:
- prior MRSA infection
- recent influenza + necrotizing pneumonia
- severe cavitary pneumonia
- IV drug use (important in correctional populations)
Add:
- vancomycin OR linezolid
Pseudomonas risk factors:
- structural lung disease (bronchiectasis)
- prior colonization
- recent hospitalization with IV antibiotics
- severe COPD with frequent exacerbations
Add:
- piperacillin-tazobactam OR cefepime OR meropenem
7. Duration of Therapy
Typical CAP:
- 5 days minimum
- must be clinically stable (afebrile, improving, stable vitals)
Longer if:
- MRSA
- Pseudomonas
- complications
- bacteremia
8. Correctional Facility–Associated Pneumonia (Important Add-On)
There is no separate official “correctional pneumonia guideline,” but correctional settings behave like a high-risk congregate environment, similar to shelters or nursing facilities in terms of epidemiology.
So you adjust thinking in 4 ways:
A. Higher Risk of TB
In correctional settings you must ALWAYS consider:
Tuberculosis red flags:
- chronic cough >2–3 weeks
- night sweats
- weight loss
- hemoptysis
- fevers
If suspected:
- isolate immediately
- airborne precautions
- chest X-ray
- sputum testing
👉 TB is the “don’t miss” diagnosis in corrections.
B. Higher MRSA Prevalence
Correctional populations have:
- skin infections
- abscesses
- IV drug use history
- close-contact spread
So in severe pneumonia:
Consider MRSA if:
- cavitary lesion
- post-influenza pneumonia
- severe systemic illness
- IV drug use history (very relevant in women’s facilities too)
C. Higher Aspiration Risk
Common correctional risk factors:
- intoxication/withdrawal
- benzodiazepine use
- psychiatric sedation
- seizure disorders
Aspiration pneumonia organisms:
- oral anaerobes
- gram negatives
Treatment often:
- ampicillin-sulbactam OR
- amoxicillin-clavulanate OR
- ceftriaxone + metronidazole (less common now)
D. Delayed Presentation Bias
Patients often:
- delay reporting symptoms
- minimize illness
- present later in disease course
So you will see more:
- moderate/severe pneumonia
- hypoxia
- dehydration
- sepsis
9. HAP (Hospital-Acquired Pneumonia)
In correctional infirmaries or hospitals:
Empiric therapy must cover:
- MRSA
- Pseudomonas
Typical regimen:
- piperacillin-tazobactam OR cefepime OR meropenem
PLUS - vancomycin or linezolid
10. When to Send Out Immediately (Correctional Triage Rule)
Transfer to ED/hospital if:
Respiratory compromise:
- SpO₂ <90–92%
- increased work of breathing
- cyanosis
Systemic instability:
- hypotension
- tachycardia with fever
- altered mental status
Severe pneumonia signs:
- multilobar infiltrates
- suspected sepsis
- inability to take PO meds
11. Antibiotic Choices Summary (Quick Reference)
Mild outpatient CAP:
- amoxicillin OR doxycycline
Outpatient with comorbidities:
- amox-clav + doxy/azithro OR levofloxacin
Inpatient non-ICU:
- ceftriaxone + azithromycin OR levofloxacin
Severe/ICU:
- ceftriaxone + azithromycin
OR - respiratory fluoroquinolone
± MRSA/Pseudomonas coverage if risk
12. Key Clinical Pearls
1. Do NOT overuse broad-spectrum antibiotics
Most CAP is still:
- pneumococcus
- atypicals
2. IV drug use changes everything
Think:
- MRSA pneumonia
- endocarditis with septic emboli
3. Pneumonia + chest pain + hemoptysis
→ consider:
- PE
- TB
- cavitary MRSA
4. Flu season matters
Post-influenza pneumonia → MRSA risk increases significantly.
5. Correctional environment = outbreak vigilance
If multiple patients present with respiratory illness:
- consider viral outbreak
- influenza
- COVID
- TB cluster (rare but critical)
13. Bottom Line
Pneumonia management is:
Step 1:
Assess severity (outpatient vs inpatient vs ICU)
Step 2:
Choose empiric antibiotics based on:
- CAP vs HAP
- MRSA risk
- Pseudomonas risk
Step 3:
Always consider correctional modifiers:
- TB risk
- MRSA prevalence
- aspiration risk
- delayed presentation
Step 4:
Treat for 5+ days and reassess clinical stability (not just imaging)
If you want, I can next give you a “correctional respiratory infection algorithm” (pneumonia vs TB vs asthma vs COPD vs PE triage flow) because that’s one of the highest-yield decision tools in your setting.